Scholarlink

Background <p>The current study aims to investigate the association between dietary total antioxidant capacity (DTAC) and overall survival (OS) in patients with ovarian cancer (OC).</p> Methods <p>A validated 111-item food frequency questionnaire was used to assess their pre- and post-diagnosis dietary intake. DTAC is represented by ferric-reducing ability of plasma (FRAP), total oxygen radical absorbance capacity (TORAC), hydrophilic oxygen radical absorbance capacity (HORAC), lipophilic oxygen radical absorbance capacity (LORAC), and total phenolics (TP). The OS was determined by both passive and active follow-up.</p> Results <p>A total of 531 patients with OC was involved in this study. High post-diagnosis FRAP (HR<sub>T3 vs. T1</sub>=0.65, 95%CI = 0.42–0.99), post-diagnosis TORAC (HR<sub>T3 vs. T1</sub>=0.68, 95%CI = 0.47–0.98), and pre-diagnosis LORAC (HR<sub>T3 vs. T1</sub>=0.62, 95%CI = 0.43–0.89) had statistically significant association with an improved OS. Additionally, increased DTAC consumption (FRAP: HR <sub>Low−Medium</sub>=0.53, 95%CI = 0.30–0.95; FRAP: HR <sub>Low−High</sub>=0.46, 95%CI = 0.23–0.93; LORAC: HR <sub>Medium−High</sub>=0.50, 95%CI = 0.27–0.91), as well as maintaining high or medium DTAC consumption (TORAC: HR <sub>Medium−Medium</sub>=0.46, 95%CI = 0.26–0.83; TORAC: HR <sub>High−High</sub>=0.57, 95%CI = 0.34–0.96; LORAC: HR <sub>High−Medium</sub>=0.43, 95%CI = 0.23–0.82), improved the OS in patients with OC.</p> Conclusions <p>Increased pre- and post-diagnosis DTAC intake, and maintaining moderate or high DTAC intake after diagnosis, may be associated with enhanced OS in patients with OC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pre- and post-diagnosis dietary total antioxidant capacity and overall survival in patients with ovarian cancer: a prospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月1日

查看全文
  • Dong-Hui Huang,
  • Lei Wang,
  • Xiao-Ying Li,
  • Ying Qin,
  • Fang-Hua Liu,
  • Yi-Zi Li,
  • He-Li Xu,
  • Fan Cao,
  • Lang Wu,
  • Yi-Fan Wei,
  • Song Gao,
  • Ting-Ting Gong,
  • Yu-Hong Zhao,
  • Qi-Jun Wu

摘要

Background

The current study aims to investigate the association between dietary total antioxidant capacity (DTAC) and overall survival (OS) in patients with ovarian cancer (OC).

Methods

A validated 111-item food frequency questionnaire was used to assess their pre- and post-diagnosis dietary intake. DTAC is represented by ferric-reducing ability of plasma (FRAP), total oxygen radical absorbance capacity (TORAC), hydrophilic oxygen radical absorbance capacity (HORAC), lipophilic oxygen radical absorbance capacity (LORAC), and total phenolics (TP). The OS was determined by both passive and active follow-up.

Results

A total of 531 patients with OC was involved in this study. High post-diagnosis FRAP (HRT3 vs. T1=0.65, 95%CI = 0.42–0.99), post-diagnosis TORAC (HRT3 vs. T1=0.68, 95%CI = 0.47–0.98), and pre-diagnosis LORAC (HRT3 vs. T1=0.62, 95%CI = 0.43–0.89) had statistically significant association with an improved OS. Additionally, increased DTAC consumption (FRAP: HR Low−Medium=0.53, 95%CI = 0.30–0.95; FRAP: HR Low−High=0.46, 95%CI = 0.23–0.93; LORAC: HR Medium−High=0.50, 95%CI = 0.27–0.91), as well as maintaining high or medium DTAC consumption (TORAC: HR Medium−Medium=0.46, 95%CI = 0.26–0.83; TORAC: HR High−High=0.57, 95%CI = 0.34–0.96; LORAC: HR High−Medium=0.43, 95%CI = 0.23–0.82), improved the OS in patients with OC.

Conclusions

Increased pre- and post-diagnosis DTAC intake, and maintaining moderate or high DTAC intake after diagnosis, may be associated with enhanced OS in patients with OC.